Binu Susan Mathew Selected Research

5-fluorodihydrouracil

1/2021

Systemic exposure to 5-fluorouracil and its metabolite, 5,6-dihydrofluorouracil, and development of a limited sampling strategy for therapeutic drug management of 5-fluorouracil in patients with gastrointestinal malignancy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Binu Susan Mathew Research Topics

Disease

2	Tuberculosis (Tuberculoses) 01/2019 - 05/2018
1	Critical Illness (Critically Ill) 06/2022
1	Hypoalbuminemia 06/2022
1	Neoplasms (Cancer) 01/2021
1	Malaria 07/2019
1	Pain (Aches) 07/2019
1	Cough 04/2013

Drug/Important Bio-Agent (IBA)

2	Rifampin (Rifampicin)FDA LinkGeneric 01/2019 - 05/2018
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2019 - 05/2018
1	AlbuminsIBA 06/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 06/2022
1	5-fluorodihydrouracilIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 07/2019
1	ArtesunateIBA 07/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 04/2013

Therapy/Procedure

1	Therapeutics 05/2018